⏳ Fetching live dividend data...
Home › Calculator › BICTF Dividend Calculator 2026
Biocure Technology Inc. · OTC
Price: $0.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in BICTF → $1.0763674952097692e+21M in 10 years · $89,251,036,087,045,560,000,000,000.00/month
Biocure Technology Inc., along with its subsidiary, is dedicated to the development and market introduction of biopharmaceutical technologies, particularly those leveraging recombinant proteins and ranibizumab. The company's therapeutic pipeline features Interferons-ß, which are being advanced for the treatment of multiple sclerosis. They are also developing Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related ocular condition known as macular edema. Furthermore, Biocure is progressing Filgrastim, a treatment for neutropenia—a deficiency of white blood cells often resulting from cancer, bone marrow transplantation, chemotherapy, or other health issues. Beyond these, Biocure Technology is actively engaged in the research and development of innovative CAR T Cell therapy, intended to pinpoint and destroy cancer cells. Their investigative efforts also encompass a vaccine for foot and mouth disease and a variety of hair growth solutions. Established in 2005, the company's main operations are situated in Vancouver, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BICTF position with:
Real after-tax yield depends on where you live and how you hold BICTF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 20000.00% | 19997.20% | $2,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 17000.00% | 16997.20% | $1,700,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 16000.00% | 15997.20% | $1,600,000 / yr |
| 🇬🇧 UK ISA | 0% | 20000.00% | 19997.20% | $2,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 18250.00% | 18247.20% | $1,825,000 / yr |
| 🇨🇦 TFSA | 0% | 20000.00% | 19997.20% | $2,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 15000.00% | 14997.20% | $1,500,000 / yr |
| 🇦🇺 Super (pension) | 15% | 17000.00% | 16997.20% | $1,700,000 / yr |
| 🇦🇺 AU Taxable | 30% | 14000.00% | 13997.20% | $1,400,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 14725.00% | 14722.20% | $1,472,500 / yr |
| 🇫🇷 FR Taxable | 30% | 14000.00% | 13997.20% | $1,400,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BICTF pays quarterly — 4 times per year. Next ex-div: TBD.
How BICTF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BICTF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BICTF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Biocure Technology Inc. (BICTF) is currently trading at $0.01, 99% below its 52-week high. The current dividend yield is 20000.00% based on an annual payout of $2.00 per share.
Biocure Technology Inc. (BICTF) is a healthcare stock currently trading at $0.01 with a dividend yield of 20000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever